Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBI-8000 in Combination With Nivolumab in Advanced Solid Tumors
NCT02718066Phase 2Completed
- Sponsor
- HUYABIO International, LLC
- Start
- Aug 2016
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tucidinostat in melanoma, renal cell carcinoma (RCC), non-small cell lung cancer (NSCLC), sponsored by HUYABIO International, LLC. Started Aug 2016; status: completed.
02
Drugs
tucidinostat
03
Conditions
melanomarenal cell carcinoma (RCC)non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02718066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02718066.